Dare Bioscience | Results Presentation Deck | 14 slides

Daré Bioscience · 2023-11
arc beats above · slides in the middle · loops below · scroll → 1 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

3
coverage by narrative range · generated from this deck JSON

Slide inventory

14
every slide · same image gating as the playbook
01
Slide 1
Includes company branding and a tagline explaining the name origin.front_matter
03
The slide uses a logo grid to establish credibility through association with major pharmaceutical companies.summarize
04
The slide uses a Gantt-style visualization to track drug development progress.plan_implementation
Open slide detailBeat · Solution
05
The slide outlines the clinical strategy for a topical sildenafil product, referencing DSM-5 definitions and FDA meeting timelines.summarize
Open slide detailBeat · Solution
06
Includes logos for Bayer and NIH/NICHD.summarize
Open slide detailBeat · Solution
07
Includes Organon logo and disclaimer text at the bottom.summarize
Open slide detailBeat · Solution
08
The slide uses a circular flow diagram to show how these three strategic pillars reinforce each other.present_framework
09
The slide uses a bulleted list to outline upcoming events for XACIATO, Ovaprene, Sildenafil Cream, and DARE-PDM1.plan_implementation
11
The slide uses a clear two-column layout to contrast clinical definitions with market prevalence data.diagnose_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
12
The slide uses a combination of demographic data and competitive product benchmarks to frame the market opportunity.size_opportunity
Open slide detailBeat · Market SizeLoop · Cost Of Inaction
13
The slide uses a hub-and-spoke diagram to segment the addressable market.size_opportunity
Open slide detailBeat · Market SizeLoop · Cost Of Inaction
14
Standard pharmaceutical safety disclosure slide.other
Open slide detailLoop · Cost Of Inaction